SCHEMBL31695346

SCHEMBL31695346

N#Cc1c(-c2ccc(O)c(O)c2)cc(-c2ccccc2)[nH]c1=N

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ATM Q13315 1/20 0.51
▸ PIM1 P11309 5/20 0.49
▸ BIRC5 O15392 3/20 0.49
▸ ALDH1A1 P00352 5/20 0.48
▸ MAPT P10636 3/20 0.48
▸ MEN1 O00255 3/20 0.48
▸ KMT2A Q03164 3/20 0.48
▸ MET P08581 3/20 0.46
▸ KDR P35968 3/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ TDP1 Q9NUW8 1/20 0.45
▸ NPSR1 Q6W5P4 1/20 0.45
▸ ALOX5 P09917 1/20 0.42
▸ APP P05067 1/20 0.42
▸ POLB P06746 1/20 0.42
▸ KDM4E B2RXH2 2/20 0.41
▸ GAA P10253 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ GLA P06280 1/20 0.41
▸ PKM P14618 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31695345 0.99 ATM (0.50) ATMPIM1BIRC5ALDH1A1MAPT
SCHEMBL31695348 0.91 PIM1 (0.47) ATMPIM1BIRC5ALDH1A1MAPT
SCHEMBL31695323 0.88 MAPT (0.50) ATMPIM1BIRC5ALDH1A1MAPT
SCHEMBL31695313 0.88 IL4 (0.54) ATMPIM1BIRC5ALDH1A1MAPT
SCHEMBL31695357 0.88 IL4 (0.45) ATMPIM1BIRC5ALDH1A1MAPT
SCHEMBL29335418 0.88 IL4 (0.54) ATMPIM1BIRC5ALDH1A1MAPT
SCHEMBL31695347 0.88 ALOX5 (0.49) ATMPIM1BIRC5ALDH1A1MAPT
SCHEMBL31695290 0.86 MET (0.48) PIM1BIRC5ALDH1A1MAPTMET
SCHEMBL23841109 0.83 ATM (0.72) ATMPIM1BIRC5MEN1KMT2A
SCHEMBL23841138 0.81 ATM (0.57) ATMPIM1BIRC5ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250313530-A1 SMALL MOLECULE INHIBITORS OF INTERLEUKIN-4 AND USES THEREOF TRUSTEES OF BOSTON UNIVERSITY (US) 2025-10-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250313530-A1 SMALL MOLECULE INHIBITORS OF INTERLEUKIN-4 AND USES THEREOF IL4, IRAK4, IL5 ATM 1125/4885PIM1 585/4885BIRC5 636/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback